CUSIP No. 114082100
Item 1(a). Name of Issuer: The name of the issuer is Brooklyn ImmunoTherapeutics Inc., a Delaware
corporation (the Issuer).
Item 1(b). Address of Issuers Principal Executive Offices: The address of the Issuers
principal executive offices is 140 58th Street, Building A, Suite 2100 Brooklyn, NY 11220.
Item 2(a). Name of Person Filing: This statement
is jointly filed by Custard & Pitts Investment Co. LP, a Texas limited partnership, William A. Custard and W. Allen Custard III (collectively the Reporting Persons).
Item 2(b). Address of Principal Business Office or, if None, Residence: The principal business office address of the Reporting Persons is 4600
Greenville Avenue, 3rd Floor, Dallas, Texas 75206.
Item 2(c). Citizenship: Custard &
Pitts Investment Co. LP is organized under the laws of the state of Texas. William A. Custard and W. Allen Custard III are both citizens of the United States of America.
Item 2(d). Title of Class of Securities: Common Stock, par value $0.005 per share (the Common Stock).
Item 2(e). CUSIP Number: 114082100
Item 3. If
this statement is filed pursuant to § 240.13d-1(b), or § 240.13d-2(b) or (c), check whether the person filing is a:
(a) ☐ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
(b) ☐ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) ☐ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
(d) ☐ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C.
80a-8).
(e) ☐ An investment adviser in accordance with §
240.13d-1(b)(1)(ii)(E);
(f) ☐ An employee benefit plan or endowment fund in accordance with
§ 240.13d-1(b)(1)(ii)(F);
(g) ☐ A parent holding company or control person in
accordance with § 240.13d-1(b)(1)(ii)(G);
(h) ☐ A savings association as defined in
Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i) ☐ A church plan that is excluded from the definition of
an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j) ☐ A non-U.S. institution in accordance with §
240.13d-1(b)(1)(ii)(J).
(k) ☐ Group, in accordance with § 240.13d-1(b)(1)(ii)(K).
If filing as a non-U.S. institution in
accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
5